PAR 4.08% 23.5¢ paradigm biopharmaceuticals limited..

The quarterly clearly states - outflow of 8-11m which included...

  1. 727 Posts.
    lightbulb Created with Sketch. 165
    The quarterly clearly states - outflow of 8-11m which included the R&D refund . It is "net outflow" . They had $33m as at end of last quarter so $23 -$25m is what they have guided for March quarter then dropping to $6-8m which included phase 3 stage 2 restart costs.

    "Forecast cash outflow for the March 2024 quarter is expected to be $8 - $11m (including
    R&D refund
    ) and the June 2024 quarter expected to be in the $6m - $8m range which is
    inclusive of phase 3 stage 2 restart costs. "
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
-0.010(4.08%)
Mkt cap ! $82.20M
Open High Low Value Volume
26.0¢ 26.0¢ 23.0¢ $317.0K 1.319M

Buyers (Bids)

No. Vol. Price($)
2 49998 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 16000 2
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
23.5¢
  Change
-0.010 ( 6.00 %)
Open High Low Volume
25.0¢ 26.0¢ 23.0¢ 531376
Last updated 15.58pm 06/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.